Brady Todd C - Insider Non-Derivative Transactions at Aldeyra Therapeutics, Inc. (ALDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 12, 2024, Brady Todd C's relationship to Aldeyra Therapeutics, Inc. (ALDX) is Director,Officer (President and CEO), and currently has 1,471,298 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALDX insiders.
Data Source: SEC.
Brady Todd C - Insider Non-Derivative Transactions of ALDX Common Stock
Brady Todd C - Insider Non-Derivative Transactions at ALDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 13, 2024 | Sell -- (Common Stock) | 85324 | 3.05 | 1471298 |
| Mar 12, 2024 | Sell -- (Common Stock) | 97914 | 3.27 | 1556622 |
| Sep 8, 2023 | M -- (Common Stock) | 192084 | 0.55 | 1647369 |
| Sep 8, 2023 | F -- (Common Stock) | 73807 | 7.22 | 1654536 |
| Sep 8, 2023 | M -- (Common Stock) | 32953 | 0.55 | 1680322 |
| Sep 8, 2023 | M -- (Common Stock) | 48021 | 0.55 | 1728343 |
| Mar 1, 2023 | Acquisition -- (Common Stock) | 238750 | 0 | 1455285 |